A/s Novo, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 666,666 shares at $15.00 ($10.0M) on 2016-03-29, disclosed to the SEC on 2016-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |